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Abstract
Background: Benefits of physical activity in the management of diabetes are well documented. However, evidence
on the effectiveness of interventions integrating physical activity in diabetes care is sparse especially in the
countries of the Gulf Cooperation Council. The results from this study will increase our understanding of the use of
multi-component interventions aimed at increasing physical activity levels in inactive adults with type 2 diabetes in
primary health care in Oman.
Methods/design: The study is a one year 1:1 cluster randomized controlled trial of the MOVEdiabetes programme
(intervention) versus usual care in eight primary health care centres in Oman. The MOVEdiabetes programme
utilizes face to face physical activity consultations promoting 150 min of moderate to vigorous physical activity per
week (≥600MET-mins/week), pedometers to self-monitor step counts and monthly telephone WhatsApp messages
for follow up support. Inactive adults with type 2 diabetes and no contraindication to physical activity will be
recruited over a two months period, and followed up for 12 months. To demonstrate a 50% between group
difference in physical activity levels (MET-mins/week) over 12 months, (at a power of 80%, and significance level of
5%), 128 participants would be required to complete the study (64 in each arm). Based on a drop-out rate of 20%,
154 participants would require to be recruited (77 in each arm). Assuming a recruitment rate of 70%, 220 potential
eligible participants would need to be approached. The primary outcome is change in levels of physical activity
measured by the Global Physical Activity Questionnaire. In addition, accelerometers will be used in a sub group to
objectively assess physical activity. Secondary outcomes include changes in metabolic and cardiovascular
biomarkers, change in self-reported health, social support, self-efficacy for physical activity, and perceived
acceptability of the program. All intervention delivery and support costs will be monitored.
Discussion: This study will contribute to the evidence on the feasibility, cultural acceptability and efficacy of
interventional approaches for increasing physical activity in primary care for persons with type 2 diabetes in Oman.
Trial registration: International Standard Randomised Controlled Trials No: ISRCTN14425284. Registered 12 April 2016.
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Background
The International Diabetes Federation (IDF) estimates
that 8.3% of people globally have diabetes (382 million),
90% of which is type 2 diabetes (T2D) and the numbers
affected are expected to increase by 55% (to 592 million)
by 2035 [1]. In countries of the Middle East and North Af-
rica (MENA) region, the impact of diabetes is a major
concern, especially in the Arab Gulf countries which have
the highest prevalence of diabetes in the world [2].
Oman, similar to the other high income countries of the
Gulf Cooperation Council (GCC) [3], has gone through
rapid economic development leading to high energy dense
diets and sedentary lifestyles [4]. Diabetes prevalence in
Oman increased from 8.3% in 1991 to 11.6% in 2000 and
12.3% in 2008 and recent estimates are in the order of
14.2% [1, 5]. Oman and other GCC countries are facing
similar challenges related to management of diabetes and
the IDF has estimated that the MENA will have a 96% in-
crease in the number of people with diabetes by 2035 [1, 6].
The evidence around the impact of physical activity (PA)
on both the prevention and management of T2D is well
documented [7, 8]. To reach the clinical benefits of PA, the
World Health Organization (WHO) recommends at least
150 min of moderate-intensity PA OR 75 min of vigorous-
intensity PA per week, which equates to an equivalent com-
bination of moderate- and vigorous-intensity PA achieving
at least 600 MET-min/week. Meeting physical activity rec-
ommendations has been shown to increase insulin sensitiv-
ity, lower blood sugar levels, reduce body fat and improve
physical condition [9].
Based on the best-available data derived from subjective
PA measurement tools (e.g. Global Physical Activity Ques-
tionnaire (GPAQ), International Physical Activity Question-
naire (IPAQ-Short) and locally developed questionnaires),
the population estimate for adults meeting WHO PA
recommendations in Arab countries is around 40% for men
and 27% for women [10]. A regional study in Sur (north-
east coast of Oman), using GPAQ, showed the highest
levels of physical inactivity were in leisure time (55%) and
the median sitting time was about two hours/day [11].
While in western countries (USA) it has been reported
that over 60% of patients with T2D don’t meet the recom-
mended levels of PA [12], consolidated evidence demon-
strating PA levels in populations with T2D in Arabic
countries is scarce. In Oman, the national health survey
2008 [5] reported that 15% of adults with T2D were physic-
ally active based on international recommendations
(150 min per week) while in Lebanon only 10% of adults
with T2D were reported to reach the recommended levels
of PA versus 23% with inadequate levels [13].
Evidence on the best PA interventions for patients with
T2D in primary care worldwide is unclear. Interventions
differed by settings (primary care vs community), methods
(consultations vs exercise sessions), and duration (short-
term vs long-term). PA consultations and exercise sessions
linked to theories of behaviour change seem to significantly
improve activity levels for patients with T2D [14]. Addition-
ally, technology bound interventions and the use of motiv-
ational tools, such as pedometers, have been consistently
recommended in interventional studies [15, 16]. Walking
interventions have also shown significant positive effects in
lowering glycated haemoglobin levels (HbA1c) and im-
proved diabetes health outcomes [17]. However, there is
still a gap in the evidence on the best methods, intervention
components and intervention intensity that would be most
effective in increasing long-term PA in the primary care set-
ting for persons with T2D [14, 18].
Almost all interventions have been carried out in non-
Arabic speaking countries hence, evidence for culturally
sensitive PA interventions is warranted. Based on these
gaps in knowledge, this study aims to explore uncertain-
ties about translating existing evidence from western set-
tings to local clinical settings in Oman whilst taking
account of cultural boundaries.
Methods
Primary objective
The primary objective is to evaluate the impact of a multi-
component intervention (MOVEdiabetes) which aims to
achieve 150 min of moderate to vigorous physical activity/
week (≥600MET-mins/week) in inactive adults with T2D
attending primary health care facilities in Oman.
Secondary objectives
The secondary objectives of the study are:
 Estimate the impact of MOVEdiabetes programme
on cardio-metabolic risk factors.
 To evaluate the impact of utilizing a common
telephone application, WhatsApp, as an intervention
reminder and follow up tool.
 To examine the acceptability of the intervention
(content, delivery and aims) to the participants and
project officers (health care providers).
 To assess the practical issues (including costs) that




The study is a 1 year 1:1 cluster randomized controlled trial
of the MOVEdiabetes intervention versus usual care. A
cluster randomization design was used to minimize be-
tween group contamination by having the two groups
(intervention and comparison) from independent health
centres. Group allocation will be generated using a random
numbers table generated in SPSS v21 by an independent
statistician in Oman Ministry of Health. All health centres
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(8) will be randomised to deliver either the intervention (n
= 4) or usual care (n = 4). Health centres will be informed
of their allocation verbally by the project investigator and
will receive an envelope containing invitation letter and
project materials.
Recruitment
To ensure that intervention delivery is institutionalized
within routine diabetes care in the selected health cen-
tres, three project officers will be recruited at each side
(n = 24) from existing health care providers (doctors/
nurses/dieticians/health educators). Project officers will
receive study specific training on the recruitment proce-
dures, screening the participants, recording outcome
measurements, and delivering the MOVEdiabetes inter-
vention in intervention health centres (IHC).
All eligible patients attending their routine diabetes
clinics in the selected health centers will be informed
about the study by the project officers and invited to
participate in the study. Interested patients will be
screened for physical inactivity using the Scottish




 Adults aged 18 to 60 years
 Diagnosed with type 2 diabetes
 Attending health centres for at least six months
previously for diabetes care
 Assessed by project officer as having inactive behaviour
 No contraindication to physical activity
 Able to speak and read Arabic
 Willing and able to provide written informed
consent to the study
Exclusion criteria
Patients with:
 Type 1 diabetes
 A history of myocardial infarction in the previous
6 months
 A serum creatinine >140 mmol/L (from previous
recorded readings in the electronic health
information system)
 Diabetic foot ulcers or at high risk of ulcer (severe
peripheral neuropathy)
 Repeated hypoglycaemia or severe hypoglycaemia in
previous 12 months
 No internet access for WhatsApp
 Physical activity > 150 min per week
Recruitment
Recruitment will take place over a 2 month period
(8 weeks). Inactive patients fulfilling the inclusion criteria
will be provided with a participant information sheet
about the study by the project officers and a subset of pa-
tients (40%) showing interest will be offered an accelerom-
eter to be worn for a week prior to their measurement
visits to validate the GPAQ results and as a primary meas-
urement tool to evaluate the change in METS-mins/week,
sitting time and step counts. Initially all participants (n =
220) will be offered accelerometers until the required
numbers are reached in all eight health center (n = 11).
Subsequently, an appointment will be given to all potential
participants to attend a wellbeing clinic for baseline mea-
sures, linked to their diabetes clinic, within a week. A tele-
phone call will be made to all willing participants to
remind them of their appointment and ensure activation
of the accelerometer.
At the baseline visit the project officers will seek writ-
ten informed consent and log any eligible individuals
who decline participation (Fig. 1).
Recruitment will be monitored fortnightly and efforts
to reduce loss to follow-up will be made. Participants
not attending their appointment will be called to con-
sider rescheduling their appointments. Reasonable travel
costs will be reimbursed.
Measures/assessment instruments
Baseline and follow-up data will be collected face to face
and from the electronic health information system in the
health centre (AlShifa system) (Table 1).
Intervention
The intervention group will receive the “MOVEdiabetes”
personalised PA consultations, pedometer (YAMAX
Digi-walker SW-200) to measure weekly step counts and
WhatsApp messages (Table 2).
Face to face PA consultations
Recruited participants will be offered individual consulta-
tions (maximum 20 min) by the trained project officers on
3 occasions (0, 4 and 8 weeks) (Table 2). This will be under-
taken a week after completing 7 days of accelerometer wear
in the selected participants (accelerometer group) mostly in
week 0 and 8.
The consultations aims to encourage participants to-
wards achieving 150 min of PA per week (≥600MET-
mins/week) at 12 months which has been demonstrated
to be clinically effective in diabetes management. It is
estimated that a step count of not less than 6000–7000
per day is required to achieve this goal [19]. Partici-
pants will be encouraged to increase their step counts
gradually to achieve this goal.
PA programme design based on a theory and the
behavior change techniques is widely proven to be
effective [20, 21]. The theoretical framework under-
pinning the intervention in this study is the Health
Belief Model, the Stages of Change Model and the
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Social Cognitive Theory [7]. The MOVEdiabetes per-
sonalised, multiple contact, intervention programme
will also be based on several behavior change tech-
niques based on the Abraham and Michie taxonomy
[22] which includes (a) goal-setting for PA; (b) self-
monitoring to achieve these goals; (c) frequent con-
tact to provide accountability and sustain focus; (d)
use of problem-solving to address goals and potential
barriers to achieving them; and (e) emphasis on
managing individual high-risk situations.
Pedometer
Participants will be given a pedometer (YAMAX Digi-
walker SW-200) at their baseline visit. Instructions on
how to use the pedometer, how to record their daily
steps and how to set daily step goals will be discussed by
the project officers. Participants will be asked to set indi-
vidual goals and fill in a daily step count to be submitted
to the project officers in their respective health centres
over a three month period and at 12 months.
WhatsApp
Participants receiving the intervention will be asked to
open and share a telephone WhatsApp application with
the project officers in their health centre to facilitate the
reporting of their step counts and get support during the
intervention period. Additionally, monthly standardized
physical activity motivational messages will be delivered
through this telephone application. Participants are also
invited to join a WhatsApp peer support group to share
their experiences with other MOVEdiabetes participants.
Process evaluation
Programme acceptability will be explored post-
intervention via a brief exit questionnaire with all project
officers and 50% of intervention participants randomly
selected by random number tables generated in SPSSv21
by the principal investigator. The questionnaire will ex-
plore the extent initial expectations and motivations re-
garding the programme were met, engagement with the
programme, acceptability (content, delivery and aims) of
Fig. 1 Participants flow chart
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the approach e.g. if the intervention was tailored to be
appropriate and realistic to the individual’s lifestyle, and
elements of overall rating of the project including factors
influencing willingness and ability to comply with the
programme advice.
Assessment of fidelity to protocol
Managerial:
 The project group will have monthly meetings to
discuss issues regarding the physical activity
consultations, and measurements to ensure their
compliance to intervention protocol.
 A telephone application (WhatsApp) will be used
throughout the study period by project officers
and the PI to manage the daily logistics and
administrative queries.
 Attendance sheets will be reviewed and discussed.
Qualitative:
 Audio-recording and transcription of 5 PA
consultations randomly selected by random number
tables generated in SPSSv21.
 Crosschecking of 10% of PA consultation notes
randomly selected by a recruited external assessor.
Evaluative:
 The brief exit survey will include questions on
adherence to the protocol specifically for project
officers.
Sample size
To demonstrate a 50% between group difference in
physical activity levels (MET-mins/week) over 12 months,
to be detected at a power of 80%, and significance level
of 5%, 128 participants would be required to complete




GPAQ-MET-mins/week Questionnaire B, 3 F, 12 F B, 3 F, 12 F
Accelerometer (activePALTM) Reporting step count, MET-min/week, and sitting time B, 3 F, 12 F B, 3 F, 12 F
Pedometer (YAMAX Digi-walker SW-200) Reporting step counts B, 3 F, 12 F -
Secondary outcomes
Socio-demographic data Questionnaire B B
Height (m) Stadiometer B B
Body weight (Kg) Calibrated scales B, 3 F, 12 F B, 3 F, 12 F
Waist circumference (cm) Tape measure B, 3 F, 12 F B, 3 F, 12 F
Lipid profile (mmol/l) Blood test (venous fasted sample) B, 3 F, 12 F B, 3 F, 12 F
Blood pressure (mmHg) Sphygmomanometer B, 3 F, 12 F B, 3 F, 12 F
aHbA1c (%) Blood test (fasted sample) B, 3 F, 12 F B, 3 F, 12 F
Self-assessed general health Questionnaire B, 3 F, 12 F B, 3 F, 12 F
Self-efficacy for PA Questionnaire B, 3 F, 12 F B, 3 F, 12 F
Social support for exercise Questionnaire B, 3 F, 12 F B, 3 F, 12 F
Cost analysis (description) Detailed cost description 12 F -
Exit survey Questionnaire (participants and project officers) 12 F -
(B = baseline; 3 F = 3 month follow-up, 12 F = 12 month follow-up)
awhile blood collection for HbA1c at 12 month is mandatory, it is only done at baseline and 3 month if missing from the electronic health information system or
recorded within more than 4 months prior to the measurement visits
Table 2 MOVEdiabetes intervention components
Intervention visits Weeks
0a 4 8a 12 16 20 24 28 32 36 40 44 48
Face to face physical activity
consultations
→ ↔ ←
Weekly WhatsApp step count → ↔ ↔ ←
Monthly WhatsApp messages → ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ←
aAfter 7 days of PA recordings from accelerometers in the selected sub groups
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the study (64 in each arm). Based on a drop-out rate of
20%, 154 participants would require to be recruited (77 in
each arm). Assuming a recruitment rate of 70%, 220 po-
tential eligible participants would need to be approached.
Statistical analysis
The initial quantitative analysis will be an intention-to-
treat analysis between the two cluster groups (intervention
versus control) but secondary analyses will explore the ef-
fect of actual treatment received. The initial analysis will
involve standard two-sample comparisons (parametric or
nonparametric as dictated by the distribution of the data)
looking at effect sizes at 3 and 12 months using t-tests or
Mann-Whitney tests for differences in means as well as
repeated measures or chi squared tests for differences in
proportions. Differences by health centre will be explored
and, if statistically significant will be entered in a mixed
model as a random effect. The balance of characteristics
between treatment and control arms will be tabulated and
if differences are noted, adjustment will be made for these
in linear regression models.
Results from the open-ended questions in the exit sur-
vey will be analysed thematically to identify the per-
ceived acceptability of the intervention (content, delivery
and aims) to the participants and project officers (health
care providers).
Discussion/rationale for current trial
Adults with T2D are known to have multiple comorbidities
and are generally less active than the general population
[23]. Behaviour change programmes targeting vulnerable
populations are more effective than those targeting the
population at large [24]. Additionally, use of technology
namely phone applications (WhatsApp in this study) is a
positive followup and monitoring tool to promote longterm
PA [15].
PA on a regular basis improves metabolic, blood lipid
profile control and quality of life [7]. Additionally, sev-
eral studies have shown preventive effects of physical ac-
tivity in individuals with T2D in lowering the risk of
cardiovascular disease and premature death [25].
One advantage of the primary care setting in this study
is its familiarity to potential participants. More import-
antly, when interventions are delivered in a clinical set-
ting, desired outcomes are enhanced because of better
medical endorsement and feelings of the intervention
being an integrated part of care [26].
It is hoped that results from this study will enhance
the evidence base for effective routes to increasing phys-
ical activity in inactive aduts with T2D; by assessing the
impact of MOVEdiabetes intervention on PA levels; pro-
viding a platform (feasibility evidence) for the MOVE-
diabetes intervention to be initiated in routine primary
care clinics; increase understanding of participant
engagement, barriers, opportunities; and examining cost
related issues about intervention procedures in this clin-
ical and cultural setting.
This study is of direct relevance to the ministry of
health of Oman and has the potential to significantly
enhance current government action on promoting phys-
ical activity. The study will equally assist in formulation
and implementation of suitable plans of the National
Health Policy Priorities: “5. To promote the health
awareness of the community and establish a culture of
healthy lifestyles” [27].
Conclusion
It is hoped that this research will help to inform current
policies and practices of the Omani Ministry of Health for
the use of a culturally acceptable physical activity interven-
tions as an integral part of care for clients with T2D within
the primary health care setting.
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